9 funding opportunities are listed in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest
Pasteur Foundation Postdoctoral Fellowships
Fellowship Program Deadline
For the current Call for Applicants, dossiers must be received by September 17, 2010.
Fellowship candidates who respond to the September call for applicants will be notified in November 2010 and must begin the fellowship by June 1, 2011. (Applicants who responded to the February 2010 call for applicants will be notified in April 2010; recipients must begin the fellowship by December 1, 2010.)
Thanks to the generosity of our U.S. donors, and in particular with the pace-setting support of the Florence Gould Foundation, the Pasteur Foundation administers this fellowship program to bring U.S. postdoctoral researchers to work in any one of the 130+ Institut Pasteur laboratories in Paris. Guided by the institute's administration, which seeks to develop international scientific exchanges to ensure the vitality of Institut Pasteur labs, this program is open to American citizens who are not already in France and who have received their PhD degree within the last five years.
The three-year fellowship package is $70,000 annually: $55,000 fellowship plus $15,000 bench fees to support the research.
The first step is to identify a host laboratory at the institute to sponsor your application. For a list of Institut Pasteur laboratories, please visit http://www.pasteur.fr/ip/easysite/go/03b-000010-011/
Pasteur Foundation 420 Lexington Avenue, Suite 1654 New York, New York 10170
Phone: 212.599.2050 Email: PasteurUS@aol.com
Call for Proposals: Round 6 of Grand Challenges Explorations Grants
Applications for Round 6 will be accepted until November 2, 2010 at 11:30 a.m. Pacific Time.
Topics are presented for each Grand Challenges Explorations round.
The topics for Round 6 are:
* Design New Approaches to Cure HIV Infection; * Create the Next Generation of Sanitation Technologies; * The Poliovirus Endgame: Create Ways to Accelerate, Sustain and Monitor Eradication; * Create Low-Cost Cell Phone-Based Applications for Priority Health Conditions; * Create New Technologies to Improve the Health of Mothers and Newborns.
Initial grants will be US $100,000 each, and projects showing promise will have the opportunity to receive additional funding of up to US $1 million.
The Grand Challenges in Global Health initiative is jointly administered by the Bill & Melinda Gates Foundation, the Canadian Institutes of Health Research, the Foundation for the National Institutes of Health, and the Wellcome Trust.
* For general inquires - including media inquiries - about Grand Challenges in Global Health, please contact us at
grandchallenges@gatesfoundation.org Phone: 206.709.3400
Conference Student Scholarships: HIV Evolution, Genomics, and Pathogenesis
Scholarship Deadline: November 22, 2010 (Midnight US Mountain Standard Time)
Elucidating the molecular mechanisms of HIV pathogenesis relies on understanding the complex interplay between the virus and its host. Increasingly, the field is relying on the power of comparative studies of similar viruses in other species, and on whole genome analyses to elucidate which pathways are critical. The use of evolutionary analyses of both host and virus is also providing novel insights into viral transmission and innate immune responses. This Keystone Symposia meeting will use diverse disciplines to promote further insights into the dynamic interplay between the virus and the host in areas of pathogenesis, mucosal biology, the roles of viral and host genes, and viral latency. Understanding these issues is critical for the design and development of an effective vaccine and the next generation of antiviral agents.
Keystone Symposia is offering scholarships to students and post-docs this conference season. These scholarships, of up to $1000 each, are to be used to help defray the expenses associated with conference attendance, including air (on a U.S. air carrier), ground transportation and lodging costs. Receipts will be required to receive reimbursement.
Abstracts submitted for poster presentation will be used as the basis for awarding the scholarships. Conference organizers will select the scholarship recipients based on the quality of science of the abstract and the relevance of the abstract to the conference topic. Only one application per abstract is accepted.
Keystone Symposia 221 Summit Place #272 PO Box 1630 Silverthorne, CO 80498 www.keystonesymposia.org
Financial Assistance / Student Scholarships Phone: +1 (800) 253-0685 or Ksenia Shambarger - +1 (970) 262-1230 extension 140 Fax: +1 (970) 262-0311
Conference Student Scholarships: Pathogenesis of Influenza: Virus-Host Interactions
Scholarship Deadline: January 21, 2011 (Midnight US Mountain Standard Time)
The mechanisms underlying the pathogenesis of influenza remain controversial. The direct cytopathic effects of viral replication, tissue tropism of the virus, viral-bacterial synergy, as well as innate host responses are inextricably linked and play roles to varying degrees in “seasonal,” zoonotic and pandemic influenza, examples being the pandemics of 1918 and 2009 and H5N1 avian influenza. Animal models, though indispensible, have significant limitations with regard to physiological relevance to human disease. The current symposium brings together researchers working on the virus, viral receptors and tissue tropism, innate and adaptive immunity, systems biology and clinical aspects of lung injury and host defense, to address questions on the pathogenesis of influenza. The aim will be to integrate data from animal and ex vivo / in vitro human experimental models as well as human disease to understand pathogenesis of influenza and how this may lead to effective interventions. As this symposium will take place in the aftermath of the first pandemic in 40 years, there will be a wealth of new knowledge as well as intense scientific interest in the subject. In view of the particular interest in influenza and other viral respiratory diseases generated in the Asia-Pacific region arising from the avian flu H5N1 and SARS experience, situating the meeting in Hong Kong would be particularly appropriate.
Conference Student Scholarships: Protection from HIV: Targeted Intervention Strategies
Biological efforts to prevent HIV infection center on four independent approaches: inducing adaptive immune responses through vaccination, augmenting innate responses, using peri-exposure prophylactic drug therapy, and developing microbicides and/or recombinant antiviral microbial products. While all four of these approaches have promise, they still require significant optimization and further clinical trials. Indeed, successful prevention of HIV infection will likely require a combination of these approaches. Such development efforts require a better understanding of viral and immunological events at the site of transmission. This Keystone Symposia meeting will have a focus on mucosal immunology as well as the interplay between the virus and innate and adaptive immune responses, particularly during the acute phase of the infection. Leading experts in the fields will discuss recent scientific advances in these varied approaches to preventing infection and present data from recent clinical trials testing their efficacy.
Conference Student Scholarships: Immunity in the Respiratory Tract: Challenges of the Lung Environment
Scholarship Deadline: October 26, 2010 (Midnight US Mountain Standard Time)
Recently, there has been an explosion in information about the regulation of inflammation, immunity, and immunopathology in the lung. Despite these advances, we still have only a rudimentary understanding of how these responses relate to the lung environment or how and why they translate into beneficial or detrimental effects, health or disease. The goals of this meeting are to (i) bring together allergists, immunologists, microbiologists and vaccinologists to discuss pulmonary inflammation and immunity in the context of lung biology and (ii) to build on this understanding to develop improved vaccines and therapeutic interventions for inflammatory conditions and infectious diseases that affect the lungs. Expert talks in plenary sessions will present the latest research in the field. Workshops and additional talks will add late-breaking cutting-edge results. The meeting will considerably advance our understanding of respiratory immunity.
Conference Student Scholarships: Immunologic Memory, Persisting Microbes and Chronic Disease
Scholarship Deadline: October 6, 2010 (Midnight US Mountain Standard Time)
Immunological memory can provide potent protection from infectious disease. Many infections are cleared rapidly by the immune system leaving the host with protective memory B and T cell memory. However, other host-pathogen interactions are long-term and can develop into chronic diseases. Immunological memory develops differently during these protracted infections. Prolonged host-pathogen interactions, chronic infections and co-infection with multiple pathogens can impact the host’s immune system in ways that remain incompletely understood. Moreover, the universe of microorganisms with which our immune system interacts includes not only pathogens, but also normal bacterial and viral commensal flora. The impact of these microorganisms immunological memory is only just starting to be evaluated. The goals of this meeting are to discuss: 1) cutting edge research on the mechanisms of optimal immunological memory, 2) the impact of prolonged host-microbe interactions on immunological memory and 3) how the application of cutting edge approaches to studying these issues can help generated better vaccines and immunotherapies.
Conference Student Scholarships: Tuberculosis: Immunology, Cell Biology and Novel Vaccination Strategies
Scholarship Deadline: September 20, 2010 (Midnight US Mountain Standard Time)
Tuberculosis (TB) remains a major global disease, worsened by its dangerous synergy with HIV/AIDS and increasing incidences of multi-drug and extensively-drug-resistant strains. More aggressive strains such as the East-Asian/Beijing genotype family are conquering the globe and immune reconstitution inflammatory syndrome (IRIS) increasingly occurs in HIV/M. tuberculosis co-infected individuals under antiretroviral therapy. To reverse this negative trend, increased efforts are needed within academia and industry. Recently, targeted activities have started to translate basic findings into the formulation of drug, vaccine and diagnostic candidates that are entering field trials. However, these efforts are stymied by enormous gaps in our knowledge about specific mechanisms that underlie the relationship between host, pathogen and environment in TB. This Keystone Symposium on TB will focus on these relationships covering basic and clinical research. Topics include the molecular genetics and biochemistry of the pathogen with emphasis on unique lineage and growth state-specific features and the immunology and molecular genetics of the host during latency, reactivation and active disease. Because the outcomes of TB are influenced by genetic, epigenetic and environmental influences on both host and pathogen, the meeting will highlight research on host-pathogen crosstalk at the basic cellular and molecular level as well as human studies that determine the basis of susceptibility to and severity of tuberculosis. Finally, the most recent results on clinical trials of drug and vaccine candidates will be discussed in depth. It is hoped that this meeting will provide not only deeper insights into the complex crosstalk between host and pathogen, but also information on novel measures for TB control including pre- and post-exposure vaccination strategies, combat of extensively drug-resistant strains and novel therapeutic stratagems to avoid IRIS.
Maurice Hilleman/Merck Award
ASM’s premier award for major contributions to pathogenesis, vaccine discovery, vaccine development, and/or control of vaccine-preventable diseases. The award is presented in memory of Maurice R. Hilleman, whose work in the development of vaccines has saved the lives of many throughout the world.Eligibility:The nominee must have made outstanding achievements in pathogenesis, vaccine discovery, vaccine development, and/or control of vaccine-preventable diseases.Award:A cash prize of $20,000, a commemorative medal, and travel to the ASM General Meeting where the laureate delivers the Maurice Hilleman/Merck Award Lecture. Deadline: October 1. Nominations:Nominations will be considered without updating for three years. Self-nominations and more than one nomination per nominee will not be accepted. Only one nominating form and two supporting forms are accepted per nomination. The two supporters must be persons other than the nominator who are familiar with the nominee's qualifications and accomplishments. Only one of the three individuals involved in the nomination may be employed at the nominee's institution. The nominator and supporters must not share employers. Nominations must consist of the following: * Curriculum vitae, including a list of publications, emailed to awards@asmusa.org * Nominating form * Supporting formASM awards are granted at the discretion of the award selection committees and may not be awarded every year. Sponsor: Merck & Co., Inc.
American Society for Microbiology1752 N Street, N.W.Washington, D.C. 20036-2904(202) 737-3600
1